Puma Biotechnology (PBYI) Assets: 2017-2025
Historic Assets for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $202.9 million.
- Puma Biotechnology's Assets fell 8.09% to $202.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.9 million, marking a year-over-year decrease of 8.09%. This contributed to the annual value of $213.3 million for FY2024, which is 7.46% down from last year.
- Per Puma Biotechnology's latest filing, its Assets stood at $202.9 million for Q3 2025, which was up 4.08% from $194.9 million recorded in Q2 2025.
- Puma Biotechnology's Assets' 5-year high stood at $260.0 million during Q2 2021, with a 5-year trough of $193.7 million in Q2 2022.
- Moreover, its 3-year median value for Assets was $203.6 million (2023), whereas its average is $207.1 million.
- In the last 5 years, Puma Biotechnology's Assets rose by 14.69% in 2021 and then decreased by 25.52% in 2022.
- Quarterly analysis of 5 years shows Puma Biotechnology's Assets stood at $226.6 million in 2021, then decreased by 2.00% to $222.1 million in 2022, then rose by 3.81% to $230.5 million in 2023, then dropped by 7.46% to $213.3 million in 2024, then dropped by 8.09% to $202.9 million in 2025.
- Its last three reported values are $202.9 million in Q3 2025, $194.9 million for Q2 2025, and $196.2 million during Q1 2025.